Algiax Pharmaceuticals

Disarming Chronic Neuro­pathic Pain

Algiax Pharmaceuticals researches and develops inno­vative pro­ducts for the treat­ment of diseases with high unmet medical demand. The core of the develop­ment is AP-325, a low-molecular GABAA receptor modulator, which is currently in clinical develop­ment as a therapy for neuro­pathic pain.

Code Intelligence Overview Thermosome